Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May;149(5):2051-61.
doi: 10.1210/en.2007-1068. Epub 2008 Feb 14.

Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice

Affiliations

Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice

V E DeMambro et al. Endocrinology. 2008 May.

Abstract

IGF-binding protein-2 (IGFBP-2) is a 36-kDa protein that binds to the IGFs with high affinity. To determine its role in bone turnover, we compared Igfbp2(-/-) mice with Igfbp2(+/+) colony controls. Igfbp2(-/-) males had shorter femurs and were heavier than controls but were not insulin resistant. Serum IGF-I levels in Igfbp2(-/-) mice were 10% higher than Igfbp2(+/+) controls at 8 wk of age; in males, this was accompanied by a 3-fold increase in hepatic Igfbp3 and Igfbp5 mRNA transcripts compared with Igfbp2(+/+) controls. The skeletal phenotype of the Igfbp2(-/-) mice was gender and compartment specific; Igfbp2(-/-) females had increased cortical thickness with a greater periosteal circumference compared with controls, whereas male Igfbp2(-/-) males had reduced cortical bone area and a 20% reduction in the trabecular bone volume fraction due to thinner trabeculae than Igfbp2(+/+) controls. Serum osteocalcin levels were reduced by nearly 40% in Igfbp2(-/-) males, and in vitro, both CFU-ALP(+) preosteoblasts, and tartrate-resistant acid phosphatase-positive osteoclasts were significantly less abundant than in Igfbp2(+/+) male mice. Histomorphometry confirmed fewer osteoblasts and osteoclasts per bone perimeter and reduced bone formation in the Igfbp2(-/-) males. Lysates from both osteoblasts and osteoclasts in the Igfbp2(-/-) males had phosphatase and tensin homolog (PTEN) levels that were significantly higher than Igfbp2(+/+) controls and were suppressed by addition of exogenous IGFBP-2. In summary, there are gender- and compartment-specific changes in Igfbp2(-/-) mice. IGFBP-2 may regulate bone turnover in both an IGF-I-dependent and -independent manner.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Serum IGFBP-2 levels at 16 wk of age; n = 6 for each genotype and sex. *, P ≤ 0.05 for comparison of male with female Igfbp2+/+.
Figure 2
Figure 2
Micro-CT images at 8 wk of age. A, Cortical compartment for Igfbp2−/− and Igfbp2+/+ control male and females; B, distal trabecular compartment for the Igfbp2−/− and Igfbp2+/+ control males.
Figure 3
Figure 3
Bone marrow stromal cultures of Igfbp2−/− and Igfbp2+/+ control males. A, At d 18 in culture, adherent OB progenitor cells were identified by alkaline phosphatase staining (CFU-ALP) and were counterstained with von Kossa for mineral deposits (CFU-OB); B, numbers of osteoclast cells in the bone marrow stromal cultures of Igfbp2−/− and Igfbp2+/+ control mice. At d 7, the cells were fixed and stained for TRAP. TRAP-positive multinucleated (more than three nuclei) osteoclasts were then counted using light microscopy. The Igfbp2−/− males had a significant reduction in the number of osteoclast cells (*, P ≤ 0.05), whereas there was only a trend for reduced numbers in the Igfbp2−/− females (P = 0.08).
Figure 4
Figure 4
Immunoblot of PTEN. A, Aortas from Igfbp2+/+ controls and Igfbp2−/− males were lysed and processed. After SDS-PAGE, the amount of PTEN was determined by immunoblotting. The arrow denotes the position of the PTEN band. The α-actin control for loading is shown in the lower panel. B, PTEN immunoblot of osteoblast lysates from BMS cultures of Igfbp2+/+ controls and Igfbp2−/− male mice in the basal state (control), treated with 50 ng/ml IGF-I (+ IGF-I), treated with 200 ng/ml IGFBP-2 (+ IGFBP-2), and the combination of both. Data were corrected for the total amount of protein loaded as described in Materials and Methods.

Comment in

References

    1. Ricort JM 2004 Insulin-like growth factor binding protein (IGFBP) signaling. Growth Horm IGF Res 14:277–286 - PubMed
    1. Conover CA 2007 Insulin-like growth factor binding proteins and bone metabolism. Am J Physiol Endocrinol Metab 294:E10–E14 - PubMed
    1. Mohan S, Baylink DJ 2002 IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 175:19–31 - PubMed
    1. Eppig JT, Bult CJ, Kadin JA, Richardson JE, Blake JA, Anagnostopoulos A, Baldarelli RM, Baya M, Beal JS, Bello SM, Boddy WJ, Bradt DW, Burkart DL, Butler NE, Campbell J, Cassell MA, Corbani LE, Cousins SL, Dahmen DJ, Dene H, Diehl AD, Drabkin HJ, Frazer KS, Frost P, Glass LH, Goldsmith CW, Grant PL, Lennon-Pierce M, Lewis J, Lu I, Maltais LJ, McAndrews-Hill M, McClellan L, Miers DB, Miller LA, Ni L, Ormsby JE, Qi D, Reddy TB, Reed DJ, Richards-Smith B, Shaw DR, Sinclair R, Smith CL, Szauter P, Walker MB, Walton DO, Washburn LL, Witham IT, Zhu Y; Mouse Genome Database Group 2005 The Mouse Genome Database (MGD): from genes to mice: a community resource for mouse biology. Nucleic Acids Res 33:D471–D475 - PMC - PubMed
    1. Ranke M, Maier K, Schweizer R, Stadler B, Schleicher S, Elmlinger M, Flehmig B 2003 Pilot study of elevated levels of insulin-like growth factor-binding protein-2 as indicators of hepatocellular carcinoma. Horm Res 60:174–180 - PubMed

Publication types

MeSH terms

Substances